AU6648498A - Methods and compositions using interleukin-13 for enhancing immune responses - Google Patents

Methods and compositions using interleukin-13 for enhancing immune responses

Info

Publication number
AU6648498A
AU6648498A AU66484/98A AU6648498A AU6648498A AU 6648498 A AU6648498 A AU 6648498A AU 66484/98 A AU66484/98 A AU 66484/98A AU 6648498 A AU6648498 A AU 6648498A AU 6648498 A AU6648498 A AU 6648498A
Authority
AU
Australia
Prior art keywords
interleukin
compositions
methods
immune responses
enhancing immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66484/98A
Inventor
Luis J. Montaner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Publication of AU6648498A publication Critical patent/AU6648498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU66484/98A 1997-01-22 1998-01-22 Methods and compositions using interleukin-13 for enhancing immune responses Abandoned AU6648498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3634297P 1997-01-22 1997-01-22
US60036342 1997-01-22
PCT/US1998/001500 WO1998031384A1 (en) 1997-01-22 1998-01-22 Methods and compositions using interleukin-13 for enhancing immune responses

Publications (1)

Publication Number Publication Date
AU6648498A true AU6648498A (en) 1998-08-07

Family

ID=21888074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66484/98A Abandoned AU6648498A (en) 1997-01-22 1998-01-22 Methods and compositions using interleukin-13 for enhancing immune responses

Country Status (2)

Country Link
AU (1) AU6648498A (en)
WO (1) WO1998031384A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
DE602005025525D1 (en) 2004-11-17 2011-02-03 Amgen Inc COMPLETE HUMAN MONOCLONAL ANTIBODIES AGAINST IL-13

Also Published As

Publication number Publication date
WO1998031384A1 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
AU6568598A (en) Bioactive sol-gel compositions and methods
AU3641597A (en) Methods and compositions comprising r-ibuprofen
HUP0000302A3 (en) Ob fusion protein compositions and methods
HUP0004533A3 (en) Microorganism reduction methods and compositions for food
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
ZA964733B (en) Ob protein compositions and methods
AU3767097A (en) Shampoo compositions and method
AU2230199A (en) Vaccine compositions and methods of modulating immune responses
AU2825597A (en) Elastomer compositions and methods
AU3002195A (en) Fluoropolymer compositions and preparation and uses thereof
ZA968322B (en) Solid sillicone compositions and methods for their preparation and use
AU6886198A (en) Compositions and screening methods for neutrophil responses
AU7237496A (en) Methods and compositions comprising single chain recombinant antibodies
HUP9900743A3 (en) Bituminous composition and using them
AU2972597A (en) Compositions and uses thereof
AU7968398A (en) Compositions, devices, kit and method for modulating immune response
AU3002895A (en) Compositions for enhancing immune function
AU4876397A (en) Insecticidal compositions and methods
AU2273397A (en) Methods and compositions for modulating an immune response
AU7134598A (en) Plant propagation compositions and methods
AU3179999A (en) Methods to treat undesirable immune responses
AU2208995A (en) Composition for use in raising an immune response
AU1146897A (en) Methods and compositions concerning allergy in dogs
HUP0000280A3 (en) Canine ob protein compositions and methods